2Radin NS. Killing cancer cells by poly-drug elevation of ceramide levels-A hypothesis whose time has come[ J] ? Eur J Biochem, 2001,268(2) : 193-204.
3Bose R, Verheij M, Haimovitz-Friedman A, et al. Ceramide synthase mediates daunorubicin-induced apoptosis : an alternative mechanism for generating death signals[J]. Cell, 1995,82(3) :405-414.
4Jaffrezou JP, Levade T, Bettaieb A, et al. Daunorubicin-induced apoptosis : triggering of ceramide generation through sphingomyelin hydrolysis[ J]. EMBO J, 1996,15 (10) : 2417-2424.
5Lucci A, Han TT, Liu YY, et al. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxic [J]. Int J Oncol, 1999,15(3) :541-546.
6Liu YY, Han TY, Giuliano AE, et al. Eepression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells[J]. J Biol Chem, 1999,274(2) :1140-1146.
8Lavie Y, Cao Ht, Volner A, et al. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glucosylation in human cancer calls[J] .J Biol Chem, 1997,272(3):1682-1687.
9Spinedi A, Bartolomeo SD, Piscentini M. Apoptosis induced by N-hexanoylsphingesine in CHP-100 cells associates with accumulation of endogenous ceramide and is potentiated by inhibition of glucocerebreside synthesis[J]. Cell Death Differ, 1998,5(9) :785-791.
10Rosenwald AG, Pagano RE. Effects of ihe glucosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells[J] .J Lipid Res, 1994,.35(7):1232-1240.
